Background
RLS, HIV drug resistance mutations, HIV DRMs
Kenya has one of the highest HIV prevalence rates in the world, approximately 4.2% in 2020 among adults, with an estimated 870,000 women living with HIV (WLHIV) and 82,500 children living with HIV (CLHIV) [While there are a variety of underlying causes for lower VS rates in both WLHIV and CLHIV, HIV drug resistance mutations (DRMs) account for some treatment failures [International groups, including the Joint United Nations Programme on HIV/AIDS and the World Health Organization, have raised concerns regarding the rate at which HIV DRMs are increasing in resource-limited settings (RLS) [Recognizing the role HIV DRMs play in individual treatment determinations as well as for national policy guidance, many RLS have been scaling up DRM testing [